AO7

AO7, also known as 7-Aminocephalosporanic Acid, is a semisynthetic cephalosporin antibiotic. It is a member of the third generation of cephalosporin antibiotics, which are characterized by their broad spectrum of activity against both Gram-positive and Gram-negative bacteria. AO7 was first synthesized in the 1970s and has since been used in veterinary medicine for the treatment of bacterial infections in animals. Its mechanism of action involves inhibiting the synthesis of bacterial cell walls, leading to bacterial cell death. AO7 is typically administered via injection and is known for its effectiveness against a wide range of bacterial pathogens. However, like all antibiotics, the use of AO7 should be carefully monitored and prescribed by healthcare professionals to minimize the risk of antibiotic resistance. The exact chemical structure of AO7 includes a beta-lactam ring, a cephem ring, and various side chains that contribute to its antibiotic properties.